The endothelin signaling pathway plays a crucial role in melanocyte differentiation and migration. In this study, we investigated whether germline mutations of endothelin recep tor B ( EDNRB ), a gene involved in Hirschsprung disease (HSCR), could also predispose for malignant mela noma (MM). The coding region of EDNRB was sequenced in 137 MM patients and in 130 ethnically matched Caucasian control subjects. Six nonsynonymous EDNRB variants were found in 15 patients (11%), but only two were found in four control subjects (3%, odds ratio [OR] = 3.87, 95% confi dence interval [CI] = 1.25 to 12; P = .012). Overall, 14 out of 15 MM patients carried EDNRB mutations reported in HSCR, some of which had previously been shown to lead to loss of function. In multivariable logistic regression analysis including skin type, eye and hair color, number of nevi, and dorsal lentigines (freckles), the association between EDNRB mutations and MM risk remained statisti cally signifi cant (OR = 19.9, 95% CI = 1.34 to 296.2; P = .03). Our data strongly suggest that EDNRB is involved in predisposition for two different multigenic disorders, HSCR and melanoma. 
The incidence of malignant melanoma (MM) has doubled every 10 years in most Caucasian populations ( 1 ) . Multiple phenotypic traits, including the number of melanocytic nevi, dysplastic nevi, freckling and sunburn tendencies, and severe sunburn episodes during childhood, have been shown to be MM risk factors ( 2 ) . In addition to phenotypic traits, two highly penetrating melanomapredisposing genes, CDKN2A and CDK4 , are involved in predisposition to familial cutaneous melanoma, which accounts for 5 -10% of all melanoma cases ( 3 -6 ) . Furthermore, the inheritance of melanoma can also be polygenic, involving variant alleles in several different genes ( 7 , 8 ) , including the melanocortin 1 receptor MC1R ( 9 -11 ) .
The endothelin receptor B (EDNRB) is a G-protein-coupled, seven-transmembrane receptor that interacts with endothelins (EDN1, EDN2, and EDN3), multifunctional peptides involved in many cellular and physiologic processes ( 12 ) . EDNRB signaling is required during embryogenesis for the migration of melanoblasts from the neural crest to the interfollicular epidermidis, retinal epithelium, and follicular hair ( 13 ) and plays a crucial role in regulating the number of progenitor melanocytes and melanocyte differentiation ( 14 ) . Loss of EDNRB function is associated with several genetic diseases: Hirschsprung disease (HSCR, 600155) ( 15 , 16 ) , Waardenburg syndrome 4 (WS4; OMIM 277580) ( 17 ) , and Waardenburg-Shah syndrome ( 18 ) . These diseases are characterized by major defects in the neural crest cell lineages. In addition to its role in melanocyte development, activation of the endothelin system also plays a crucial role in the skin's response to ultraviolet irradiation. EDN1, a paracrine peptide that is secreted by keratinocytes in response to UVB radiation ( 19 -21 ) , is a ligand for EDNRB and induces proliferation of mature melanocytes and stimulates melanogenesis, producing a photoprotective effect ( 22 ) .
We therefore tested the hypothesis that a germline defect of the EDNRB pathway could be associated with a genetic predisposition to melanoma. The coding sequence and intronic fl anking regions of the EDNRB gene were entirely sequenced in this case control study.
Melanoma patients (n = 137) and control subjects (n = 130) were prospectively recruited between 1999 and 2004 by the Dermatology Departments of the Bichat Claude-Bernard, the Percy, the Ambroise Paré, and the Saint-Louis Hospitals in Paris. The study population consisted of patients aged 20 -80 years with histologically confi rmed MM. Twenty-nine of the patients had at least one relative with melanoma, but none harbored a CDKN2A or a CDK4 germline mutation. The control group was extended from the one previously described ( 23 ) and was composed of individuals who had no personal or family history of skin cancer, were in the same age range, and were referred by the same departments and hospitals as the MM patients. The birthplaces of the parents and grandparents were recorded to ensure that all patients and control subjects were of Caucasian origin. The Hospital Medical Ethics Committee (CCPPRB) approved the study protocol. Informed consent was obtained from all patients and control subjects enrolled in the study.
The clinical characteristics of the MM patients and control subjects are summarized in Table 1 . The strongest risk factors identifi ed for MM were a mole count of >50 ( P <.001), the presence of an atypical mole syndrome ( P <.001), fair skin color ( P <.001), and having dorsal lentigines ( P <.001 Interestingly, three of the variants identifi ed in 14 out of 15 patients (S305N, G57S, and W276C) had previously been reported in HSCR disease, and impaired protein function had been documented for two of them ( 16 , 24 -27 ) ( Table 3 ). In addition, two of the three newly identifi ed variants (R434C and D246F) ( Table 3 ) were predicted to be damaging by the Polyphen software program ( 28 ) ( http:// tux.embl-heidelberg.de/ramensky/ ). The position of each variant is indicated on a three-dimensional model of the protein ( Supplementary Fig. 1 , available at http:// jncicancerspectrum.oxfordjournals.org/ jnci/content/vol97/issue17 ).
Fourteen patients were heterozygous for a single variant, but one patient harbored three variants (S305N, V260F, and R434C). DNA analysis of the patient's daughter revealed that V260F and R434C were located on the same allele, suggesting that the patient was compound heterozygous for two functional EDNRB variants. Interestingly, she had an explosive melanoma of the scalp.
None of the patients or control subjects carrying EDNRB variants displayed any symptoms of HSCR or gross hypopigmentation disorders. However, the presence of nonsynonymous EDNRB variants was statistically associated with skin type I/II in mela noma patients ( P = .007), although no effect on any other pigmentation characteristics could be detected. * Participants underwent a standard personal interview conducted by a dermatologist, and a total skin examination was performed and reported using a preprinted examination report form. Information was recorded about skin color (classifi ed as dark, medium, or fair), eye color (classifi ed as dark [brown or black] or light [blue, green or hazel, or gray]), and original (before graying) hair color (classifi ed using fi ve categories: red, blond, light or dark brown, and black). The whole-body nevus count, the presence or absence of atypical mole syndrome (50 or more nevi, with at least three being clinically atypical, i.e., ≥ 6 mm in diameter, and characterized by variable pigmentation, indistinct borders, and irregular outline) ( 53 ) , and the presence or absence of solar lentigines, were also assessed by means of physical examination by a dermatologist. Skin types were assessed according to the Fitzpatrick classifi cation ( 54 ) as follows: always burns never tans (skin type I), always burns then tans (skin type II), always tans, sometimes burns (skin type III), and always tans, never burns (skin type IV). OR = odds ratio; CI = confi dence interval; na = not applicable; NPES = non-photo-exposed skin; MM = malignant melanoma.
† Clinical risk factors (<50 versus ≥ 50 nevi [cutpoints were chosen based on the defi nition of the atypical mole syndrome; dysplastic nevus syndrome with >50 nevi, with some of the nevi that are clinically atypical, 10 -50 represents an intermediary phenotype, and >100 represents the most at-risk phenotype3]; fair and medium versus dark skin color; red, blond, light brown versus dark brown, and black hair color; light versus dark eye color; I-II versus III-IV skin type; and presence versus absence of dorsal lentigines) and the distribution of MC1R functional variants were compared in case patients and control subjects using two-sided chi-square and P tests (Systat for Windows v. 10; SPSS Inc., Chicago, IL). The threshold of statistical signifi cance was P <.05.
‡ In addition, in the MM group, the anatomic location of the melanoma, the patient's age at diagnosis, and relevant histopathologic data were also collected.
§ The MC1R coding sequence was amplifi ed by PCR as previously described ( 23 ) . MC1R polymorphisms retained for genetic analysis were those previously shown to be loss-of-function variants by functional studies ( 55 -57 ) and/or associated with MM and/or melanoma risk ( 9 , 10 , 58 ) , associated with red hair color ( 56 ) and/or predicted to be possibly damaging by Polyphen [ http://tux.embl-heidelberg.de/ ramensky/ , ( 28 ) ]. Thus, MC1R variants identifi ed and retained for the genetic analysis were V60L, D84E, V92M, S83P, R142H, R150W, R151C, I155T, D294H, insA86, and V122M.
Multiple logistic regression analysis was performed on each skin type group separately. In the skin type I/II group, the association between EDNRB variants and melanoma risk remained statistically signifi cant (OR = 19.9, 95% CI = 1.34 to 296.21; P = .030) ( Table 4 ) , suggesting that EDNRB variants may modulate MM risk independently of pigmentation characteristics and MC1R variants.
In addition to the observed differences in allele frequencies, the pattern of genetic diversity in the coding region of the EDNRB gene was characterized by a higher number of nonsynonymous variants in patients than in control subjects. After sequencing the EDNRB gene in three unrelated chimpanzees, we observed that the EDNRB coding sequence from chimpanzee differed from the consensus human sequence by only two synonymous substitutions, thus suggesting that EDNRB is being subjected to strong purifying selection. Population surveys have shown that nonsynonymous polymorphisms were skewed to lower frequencies than were synonymous polymorphisms ( 29 -31 ) . This difference is considered to refl ect the presence of a number of moderately deleterious alleles that are maintained at a low frequency by negative selection. If such variants predispose to a disease, one can expect that they will be found not only at a higher frequency but also in a higher number amongst patients expressing the disease than in a control group of similar size. This is precisely the situation observed here for EDNRB variants in MM patients.
One possible hypothesis for the association between loss of EDNRB function and risk of MM is that a defect in EDNRB signaling could prevent melanoblasts from achieving differentiation, thus increasing the risk of their transformation into a malignant melanoma. Second, individuals with EDNRB mutations may have had fewer melanocytes -even though this was not clinically apparent -which may make them constitutively less well protected against UV radiation. Similarly, mutant EDNRB may be less effective than the wild-type receptor in inducing an effi cient response by mature mela nocytes to UV radiation (via EDN1). However, the association of EDNRB variants with MM risk persisted after stratifi cation for skin type, suggesting that the role of EDNRB variants may, at least in part, involve a pigmentationindependent mechanism.
Finally, EDNRB itself may have an important role in the pathogenesis of MM. EDNRB is widely expressed in melanocytes but downregulated in melanoma cells, possibly being related to malignancy or apoptosis ( 32 -34 ) , suggesting that inactivating mutations of EDNRB could contribute to tumor progression. Nonsynonymous  G57S  1  Ggt>Agt  1  1  D246F  3  GAc>TTc  1  0  V260F  3  Gtt>Ttt  1  0  W276C  4  tgG>tgT  1  0  S305N  4  aGt>aAt  12  3  R434C  7  Cgt>Tgt  1  0  Total  15 † The sequence is written 5 ′ -> 3 ′ for the coding strand; the mutated base is written in uppercase letters. The text in bold indicates nucleotide and amino acid changes. For SNP L277L, the given number corresponds to the number of the patients or control subjects that carried heterozygous or homozygous nucleotide changes.
‡ The association between EDNRB and MM was assessed using conventional statistical methods by comparing the patients and control subjects carrying synonymous and nonsynonymous SNPs using chi-square and P tests. All statistical tests were two sided, and the threshold of statistical signifi cance was set at P <.05. ( 16 , 25 -27 ) . ‡ Polyphen prediction determined using Polyphen software ( 28 ) . The overall EDNRB mutational rate is reported to be 4.15% in familial and sporadic cases of HSCR disease ( 16 , 35 -48 ) . However, the presence of the predisposing variant is neither necessary nor suffi cient for the disease to be expressed, and genetic interactions between several loci have been demonstrated ( 49 -52 ) .
A similar model may also apply to the genetic predisposition for melanoma, a disease with both familial and sporadic forms. Various combinations of hypomorphic alleles at different loci, including CDKN2A , EDNRB , and MC1R , may contribute to susceptibility to the disease. It will be interesting to fi nd out whether interactions between EDNRB and other loci contribute to melanoma predisposition. * Multivariable logistic regression was adjusted for clinical and genetic risk factors, such as skin type, eye and hair color, number of nevi, dorsal lentigines, MC1R , and EDNRB variants, after testing for the interactions between the EDNRB mutations and other risk factors for MM (Systat for Windows, v10; SPSS Inc., Chicago, IL). MM = malignant melanoma; OR = odds ratio; CI = confi dence interval. P values (two sided) were calculated using logistic regression.
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